BDRX

Biodexa Pharmaceuticals plc

0.99 USD
-0.07 (-6.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Biodexa Pharmaceuticals plc stock is down -9.55% since 30 days ago. The next earnings date is Jul 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 8 June’s closed higher than May.

About Biodexa Pharmaceuticals plc

Midatech Pharma plc focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme. MTX114, an immuno-suppressant for topical application in psoriasis, MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder.